Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This protocol posting deals with objectives & outcome measures of the booster phase. The objectives & outcome measures of the primary phase are presented in a separate protocol posting (NCT number = NCT00412854). This Phase IIIB study will compare GSK Biologicals' DTPa/Hib vaccine to separately administered DTPa and Hib vaccines in Chinese children 18 to 24 months of age, in terms of safety and immunogenicity.
Critère d'inclusion
- Acellular Pertussis,Diphtheria,TETANUS